Abstract:
En
|
Text:
En
|
PDF:
En
Abstract Background: Some evidence suggests an association between gut dysbiosis and cirrhosis progression. The authors investigated Gut Microbiome (GM) influence on 90-day mortality and hospitalization/rehospitalization rates in cirrhotic patients. Methods: Compensated/decompensated outpatients and decompensated inpatients were prospectively included and compared to healthy controls. Clinical, laboratory, GM, and two ratios between phyla were evaluated. Patients were followed up for 90 days for hospitalization/rehospitalization and mortality. Results: 165 individuals were included (50 compensated, 49 decompensated outpatients; 36 decompensated inpatients; 30 healthy), 48.5 % female, mean age was 61, main cirrhosis etiology was hepatitis C (27.3 %), and mostly Child-Pugh (CP) B patients, median MELD of 13. As liver disease progressed, microbiota diversity decreased between the groups (p = 0.05; p < 0.004). There were 9 deaths and 22 hospitalizations or rehospitalizations. GM composition had correlation with norfloxacin (p = 0.36, p = 0.04), encephalopathy (p = 0.31, p = 0.01), lactulose (p = 0.26, p = 0.01), 90-day mortality (p = 0.22, p = 0.04), CP (p = 0.17, p = 0.01), previous 6-month antibiotic use (p = 0.16, p = 0.01), MELD (p = 0.145, p = 0.01), ALBI (p = 0.1, p = 0.04) and 90-day hospitalization/rehospitalization (p = 0.08, p = 0.03). Firmicutes/Bacteroidetes (F/B) and Firmicutes/Proteobacteria (F/P) ratios were progressively lower and more significant and had an association with 90-day mortality (p < 0.001). Three MELD set-points (≥ 15, 18 and 20) were significantly associated with both ratios, with similar accuracies. Conclusions: GM dysbiosis was associated with higher CP, MELD, 90-day mortality and hospitalization/rehospitalization. F/B and F/P ratios were associated with 90-day mortality. Background progression (GM 90day day hospitalizationrehospitalization hospitalization rehospitalization patients Methods Compensateddecompensated Compensated controls Clinical laboratory evaluated Results 16 50 (5 compensated 4 3 healthy, , healthy) 485 48 5 48. female 61 27.3 273 27 (27. %, %) ChildPugh Child Pugh (CP 13 progressed 0.05 005 0 05 0.004. 0004 0.004 . 004 0.004) 2 rehospitalizations 036 0.36 0.04, 0.04 04 031 31 0.31 0.01, 001 0.01 01 0.01) 026 26 0.26 022 0.22 017 17 0.17 6month month 6 016 0.16 0145 145 0.145 1 0.1 008 08 0.08 0.03. 003 0.03 03 0.03) FirmicutesBacteroidetes Firmicutes Bacteroidetes FB F (F/B FirmicutesProteobacteria Proteobacteria FP P (F/P 0.001. 0001 0.001 0.001) setpoints set points ≥ ( 15 20 accuracies Conclusions 27. (27 0.0 00 000 0.00 0.3 02 0.2 014 14 0.14 0. (2